Mishra R, Gillespie D D, Youdim M B, Sulser F
Psychopharmacology (Berl). 1983;81(3):220-3. doi: 10.1007/BF00427265.
The consequences of selective monoamine oxidase (MAO) inhibition on the norepinephrine(NE)-sensitive adenylate cyclase system were determined in slices of rat cerebral cortex. The chronic administration of clorgyline, which selectively inhibited the activity of MAO-A, caused a significant decrease in the responsiveness of the noradrenergic cyclic AMP-generating system. The noradrenergic subsensitivity was accompanied by a significant decrease in the density of beta-adrenoceptors, as measured by 3H-dihydroalprenolol (DHA) binding, without altering the Kd value. However, selective inhibition of MAO-B by deprenyl did not alter the sensitivity of the cyclic AMP-generating system to NE or the specific DHA binding. The basal levels of cyclic AMP in the cortex were unaltered by the drugs. Since inhibition of MAO-A, but not MAO-B, increases the availability of NE, the results support the hypothesis that a persistent NE-receptor interaction is one of the prerequisites for the in vivo densitization of the NE-sensitive adenylate cyclase and the concomitant down-regulation of the number of beta-adrenoceptors in brain.
在大鼠大脑皮层切片中测定了选择性单胺氧化酶(MAO)抑制对去甲肾上腺素(NE)敏感的腺苷酸环化酶系统的影响。选择性抑制MAO - A活性的氯吉兰的长期给药导致去甲肾上腺素能环磷酸腺苷生成系统的反应性显著降低。通过3H - 二氢阿普洛尔(DHA)结合测定,去甲肾上腺素能亚敏感性伴随着β - 肾上腺素受体密度的显著降低,而Kd值未改变。然而,司来吉兰对MAO - B的选择性抑制并未改变环磷酸腺苷生成系统对NE的敏感性或特异性DHA结合。药物未改变皮层中环磷酸腺苷的基础水平。由于抑制MAO - A而非MAO - B会增加NE的可用性,结果支持以下假设:持续的NE受体相互作用是NE敏感的腺苷酸环化酶在体内脱敏以及大脑中β - 肾上腺素受体数量随之下调的先决条件之一。